Cedra appoints Anthony Busa

pharmafile | May 14, 2010 | Appointment | Research and Development CRO, Cedra, appointment, research and development 

Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting chief executive Thomas Wardle.

Wardle also serves as Cedra’s chief operating officer and stepped into the chief executive role after company founder David Garcia stepped down earlier this year.

Busa has over 34 years of experience in management positions including senior level management, regional and national sales and product development within the pharmaceutical and medical device industries.

“Anthony is an experienced, high caliber professional. He has a thorough understanding of how this business and industry functions,” said Wardle. “He will be a great asset to our team in terms of growth and management.”

Busa previously held senior management positions at McClintic Busa Group, dgd Research, Esoterix, Medsites and Covance.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content